×
For best experience we recommend to activate Javascript in your browser.
RSL1D1 antibody (AA 455-485)
The Rabbit Polyclonal anti-RSL1D1 antibody (Clone RB54867) (ABIN6242515) specifically detects RSL1D1 in WB.
The antibody is reactive with Human samples.
Catalog No. ABIN6242515
$383.35
$451.00
save $67.65 (-15 %)
Plus shipping costs $50.00
50 μL ABIN6578592
200 μL ABIN6242515
50 μL ABIN6578592
200 μL ABIN6242515
Delivery in 10 to 11 Business Days
Quick Overview for RSL1D1 antibody (AA 455-485) (ABIN6242515)
Target
RSL1D1
(Ribosomal L1 Domain Containing 1 (RSL1D1))
Reactivity
All reactivities for RSL1D1 antibodies
Human
Host
All hosts for RSL1D1 antibodies
Rabbit
Clonality
All clonalities for RSL1D1 antibodies
Polyclonal
Conjugate
All conjugates for RSL1D1 antibodies
This RSL1D1 antibody is un-conjugated
Application
All applications for RSL1D1 antibodies
Western Blotting (WB)
Clone
RB54867
Product Details anti-RSL1D1 Antibody
(hide)
Binding Specificity
All epitopes for RSL1D1 antibodies
AA 455-485
Purification
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This RSL1D1 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 455-485 amino acids from human RSL1D1.
Isotype
Ig Fraction
Alternatives
(show)
Application Details
(hide)
Application Notes
WB: 1:2000
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Expiry Date
6 months
Target Details for RSL1D1
(hide)
Target
RSL1D1
(Ribosomal L1 Domain Containing 1 (RSL1D1))
Alternative Name
RSL1D1
Background
Regulates cellular senescence through inhibition of PTEN translation. Acts as a pro-apoptotic regulator in response to DNA damage.
Molecular Weight
54973
UniProt
O76021
Recently viewed
(hide)
Chat with us , powered by LiveChat